Literature DB >> 8480793

Generic and alternative brand-name pharmaceutical equivalents: select with caution.

L Hendeles1, G Hochhaus, S Kazerounian.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8480793

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


× No keyword cloud information.
  8 in total

Review 1.  Generic drugs. Therapeutic equivalence.

Authors:  P A Meredith
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

2.  In Vitro Comparison of Physical Parameters, Enzyme Activity, Acid Resistance, and pH Dissolution Characteristics of Enteric-Coated Pancreatic Enzyme Preparations: Implications for Clinical Variability and Pharmacy Substitution.

Authors:  Robert J Kuhn; Sabine Eyting; Friederike Henniges; Andreas Potthoff
Journal:  J Pediatr Pharmacol Ther       Date:  2007-04

Review 3.  Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Authors:  Aaron S Kesselheim; Alexander S Misono; Joy L Lee; Margaret R Stedman; M Alan Brookhart; Niteesh K Choudhry; William H Shrank
Journal:  JAMA       Date:  2008-12-03       Impact factor: 56.272

4.  Progress in cystic fibrosis and the CF Therapeutics Development Network.

Authors:  Steven M Rowe; Drucy S Borowitz; Jane L Burns; John P Clancy; Scott H Donaldson; George Retsch-Bogart; Scott D Sagel; Bonnie W Ramsey
Journal:  Thorax       Date:  2012-10       Impact factor: 9.139

5.  Clinical efficacy and health implications of inconsistency in different production batches of antimycotic drugs in a developing country.

Authors:  Adenike A O Ogunshe; Adedayo A Adepoju; Modupe E Oladimeji
Journal:  J Pharm Bioallied Sci       Date:  2011-01

Review 6.  Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.

Authors:  Juan Tamargo; Jean-Yves Le Heuzey; Phillipe Mabo
Journal:  Eur J Clin Pharmacol       Date:  2015-04-15       Impact factor: 2.953

7.  Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

Authors:  Devi Mukkai Krishnamurty; Atoosa Rabiee; Sanjay B Jagannath; Dana K Andersen
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

8.  Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs.

Authors:  Muhammad M Hammami; Sophia J S De Padua; Rajaa Hussein; Eman Al Gaai; Nesrine A Khodr; Reem Al-Swayeh; Syed N Alvi; Nada Binhashim
Journal:  BMC Pharmacol Toxicol       Date:  2017-12-08       Impact factor: 2.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.